<h1>Mylan Inc. Receives Approval to Acquire Agila Specialities, Bringing Rs.5,168 Crore in Foreign Investment to India.</h1> The Cabinet Committee on Economic Affairs approved the proposal by M/s Mylan Inc., USA, to acquire 100% of the fully paid-up share capital of M/s Agila Specialities Private Limited. The Foreign Investment Promotion Board recommended this acquisition, which will bring approximately Rs.5,168 crore in foreign investment to India. Mylan Inc., a global pharmaceutical company incorporated in 1970 and listed on NASDAQ, operates in India through subsidiaries such as M/s Myland Laboratories Limited, M/s Mylan Pharmaceuticals Private Limited, and M/s Astrix Laboratories Limited.